{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:31:38Z","timestamp":1792186298260,"version":"4.4.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006376","name":"Georgia Southern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006376","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xphs.2026.104406","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:42:07Z","timestamp":1783467727000},"page":"104406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enhanced Zika virus suppression by coupling ribavirin with biodegradable drug delivery"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2672-2986","authenticated-orcid":false,"given":"Julissa","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"4th","given":"Asa","family":"Waterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Blahove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Saviskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briany G.","family":"Santos-Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell A.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6905-1082","authenticated-orcid":false,"given":"James R.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0001","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41541-024-00889-x","article-title":"Continuing development of vaccines and monoclonal antibodies against Zika virus","volume":"9","author":"Woodson","year":"2024","journal-title":"NPJ Vacc"},{"key":"10.1016\/j.xphs.2026.104406_bib0002","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftad036","article-title":"A review on Zika vaccine development","volume":"82","author":"Peng","year":"2024","journal-title":"Pathog Dis"},{"issue":"17","key":"10.1016\/j.xphs.2026.104406_bib0003","doi-asserted-by":"crossref","first-page":"9424","DOI":"10.3390\/ijms25179424","article-title":"Envelope protein-targeting Zika virus entry inhibitors","volume":"25","author":"Roy","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.xphs.2026.104406_bib0004","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.4014\/jmb.2403.03008","article-title":"Advancements in antiviral drug development: comprehensive insights into design strategies and mechanisms targeting key viral proteins","volume":"34","author":"Hangyu","year":"2024","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.xphs.2026.104406_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110042","article-title":"New perspective of small-molecule antiviral drugs development for RNA viruses","volume":"594","author":"Li","year":"2024","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.xphs.2026.104406_bib0006","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1021\/acsabm.4c00878","article-title":"Self-indicating polymer prodrug nanoparticles for pH-responsive drug delivery in cancer cells and real-time monitoring of drug release","volume":"7","author":"Kayal","year":"2024","journal-title":"ACS Appl Bio Mater"},{"issue":"2","key":"10.1016\/j.xphs.2026.104406_bib0007","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/09205063.2023.2279792","article-title":"Exploring the potential of pH-sensitive polymers in targeted drug delivery","volume":"35","author":"Gomte","year":"2024","journal-title":"J Biomater Sci Polym Ed"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103414","article-title":"pH and its applications in targeted drug delivery","volume":"28","author":"Abdella","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.xphs.2026.104406_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.173865","article-title":"pH-responsive membranes: mechanisms, fabrications, and applications","volume":"946","author":"Al-Shaeli","year":"2024","journal-title":"Sci Total Environ"},{"issue":"10","key":"10.1016\/j.xphs.2026.104406_bib0010","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.3390\/polym16101408","article-title":"Modern trends in polymerization-induced self-assembly","volume":"16","author":"Serkhacheva","year":"2024","journal-title":"Polymers"},{"issue":"23","key":"10.1016\/j.xphs.2026.104406_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316952","article-title":"Biodegradable polymers in biomedical applications: a review-developments, perspectives and future challenges","volume":"24","author":"Kurowiak","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2026.104406_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.601626","article-title":"Biodegradable polymeric nanoparticles for drug delivery to solid tumors","volume":"12","author":"Gagliardi","year":"2021","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.xphs.2026.104406_bib0013","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1208\/s12249-018-1009-0","article-title":"MPEG-PCL copolymeric micelles for encapsulation of azithromycin","volume":"19","author":"Wei","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0014","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/aps.2014.113","article-title":"Oral delivery of capsaicin using MPEG-PCL nanoparticles","volume":"36","author":"Peng","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.xphs.2026.104406_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1024143","article-title":"Polymeric nanoparticles-promising carriers for cancer therapy","volume":"10","author":"Xiao","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.xphs.2026.104406_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124292","article-title":"Polymeric micelles paving the way: recent breakthroughs in camptothecin delivery for enhanced chemotherapy","volume":"659","author":"Farhoudi","year":"2024","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2026.104406_bib0017","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/polym15081835","article-title":"Recent advances in nanoparticle development for drug delivery: a comprehensive review of polycaprolactone-based multi-arm architectures","volume":"15","author":"El Yousfi","year":"2023","journal-title":"Polymers"},{"issue":"6","key":"10.1016\/j.xphs.2026.104406_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17488","article-title":"Advances in drug delivery systems, challenges and future directions","volume":"9","author":"Ezike","year":"2023","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.xphs.2026.104406_bib0019","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","article-title":"Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems","volume":"22","author":"Baryakova","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.xphs.2026.104406_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coviro.2014.04.011","article-title":"Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance","volume":"8","author":"Beaucourt","year":"2014","journal-title":"Curr Opin Virol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0021","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1038\/s41598-018-22620-2","article-title":"Antiviral effect of ribavirin against HCV associated with increased frequency of G-to-A and C-to-U transitions in infectious Cell Culture Model","volume":"8","author":"Galli","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.xphs.2026.104406_bib0022","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/ph17050661","article-title":"Small molecule drugs targeting viral polymerases","volume":"17","author":"Palazzotti","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0023","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/liv.13212","article-title":"Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection","volume":"37","author":"Feld","year":"2017","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.xphs.2026.104406_bib0024","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/jnci\/58.2.209","article-title":"Absence of HeLa cell contamination in 169 cell lines derived from human tumors","volume":"58","author":"Fogh","year":"1977","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.xphs.2026.104406_bib0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF01249659","article-title":"VERO cells (Cercopithecus aethiops kidney)\u2013growth characteristics and viral susceptibility for use in diagnostic virology. (Brief report)","volume":"27","author":"Macfarlane","year":"1969","journal-title":"Arch Gesamte Virusforsch"},{"issue":"2","key":"10.1016\/j.xphs.2026.104406_bib0026","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0042-6822(56)90017-4","article-title":"A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus","volume":"2","author":"Dulbecco","year":"1956","journal-title":"Virology"},{"issue":"Suppl 2","key":"10.1016\/j.xphs.2026.104406_bib0027","first-page":"501","article-title":"Biodegradable m-PEG\/PCL core-shell micelles: preparation and characterization as a sustained release formulation for curcumin","volume":"4","author":"Danafar","year":"2014","journal-title":"Adv Pharm Bull"},{"issue":"6","key":"10.1016\/j.xphs.2026.104406_bib0028","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3390\/polym12061397","article-title":"Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis","volume":"12","author":"Das","year":"2020","journal-title":"Polymers"},{"issue":"11","key":"10.1016\/j.xphs.2026.104406_bib0029","article-title":"Application of mPEG-PCL-mPEG Micelles for anti-zika ribavirin delivery","volume":"96","author":"Blahove","year":"2024","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/092986709787002817","article-title":"Topological polar surface area: a useful descriptor in 2D-QSAR","volume":"16","author":"Prasanna","year":"2009","journal-title":"Curr Med Chem"},{"issue":"4","key":"10.1016\/j.xphs.2026.104406_bib0031","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1248\/cpb.c12-00951","article-title":"Synthesis of a novel polymeric material folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine tri-block polymer for dual receptor and pH-sensitive targeting liposome","volume":"61","author":"Xia","year":"2013","journal-title":"Chem Pharm Bull"},{"issue":"28","key":"10.1016\/j.xphs.2026.104406_bib0032","doi-asserted-by":"crossref","first-page":"7386","DOI":"10.1016\/j.biomaterials.2010.06.004","article-title":"The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles","volume":"31","author":"Kim","year":"2010","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0033","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/cancers3010061","article-title":"Doxorubicin-loaded PEG-PCL-PEG micelle using xenograft model of nude mice: effect of multiple administration of micelle on the suppression of Human breast cancer","volume":"3","author":"Cuong","year":"2010","journal-title":"Cancers"},{"key":"10.1016\/j.xphs.2026.104406_bib0034","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.colsurfb.2014.01.037","article-title":"Characteristics and release profiles of MPEG-PCL-MPEG microspheres containing immunoglobulin G","volume":"117","author":"Erdemli","year":"2014","journal-title":"Colloid Surface B"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0035","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1080\/10717544.2018.1458923","article-title":"Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies","volume":"25","author":"Yu","year":"2018","journal-title":"Drug Deliv"},{"issue":"2","key":"10.1016\/j.xphs.2026.104406_bib0036","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0003-2697(87)90157-6","article-title":"Nile red as a polarity-sensitive fluorescent probe of hydrophobic protein surfaces","volume":"167","author":"Sackett","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1016\/j.xphs.2026.104406_bib0037","doi-asserted-by":"crossref","DOI":"10.1038\/srep34069","article-title":"Synthesis, characterization and drug loading property of monomethoxy-poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(D,L-lactide) (MPEG-PCLA) copolymers","volume":"6","author":"Chu","year":"2016","journal-title":"Sci Rep"},{"issue":"23","key":"10.1016\/j.xphs.2026.104406_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312827","article-title":"The MTT assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis","volume":"22","author":"Ghasemi","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.xphs.2026.104406_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102169","article-title":"Nudix hydrolase 18 catalyzes the hydrolysis of active triphosphate metabolites of the antivirals remdesivir, ribavirin, and molnupiravir","volume":"298","author":"Jemth","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.xphs.2026.104406_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.mimet.2024.107010","article-title":"Application of MTT assay for probing metabolic activity in bacterial biofilm-forming cells on nanofibrous materials","volume":"224","author":"Stindlova","year":"2024","journal-title":"J Microbiol Methods"},{"issue":"5","key":"10.1016\/j.xphs.2026.104406_bib0041","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/infdis\/152.5.938","article-title":"A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT","volume":"152","author":"Levitz","year":"1985","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/j.xphs.2026.104406_bib0042","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1128\/MCB.25.15.6427-6435.2005","article-title":"Polyadenylation and degradation of human mitochondrial RNA: the prokaryotic past leaves its mark","volume":"25","author":"Slomovic","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.xphs.2026.104406_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11130","article-title":"Low-cost SYBR green-based RT-qPCR assay for detecting SARS-CoV-2 in an Indonesian setting using WHO-recommended primers","volume":"8","author":"Rahmasari","year":"2022","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.xphs.2026.104406_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255314","article-title":"Zika virus isolation, propagation, and quantification using multiple methods","volume":"16","author":"Dangsagul","year":"2021","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2026.104406_bib0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijpharm.2013.06.071","article-title":"Synthesis and micellization of a pH-sensitive diblock copolymer for drug delivery","volume":"455","author":"Koutroumanis","year":"2013","journal-title":"Int J Pharm"},{"issue":"21","key":"10.1016\/j.xphs.2026.104406_bib0046","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1021\/jo971176v","article-title":"NMR chemical shifts of common laboratory solvents as trace impurities","volume":"62","author":"Gottlieb","year":"1997","journal-title":"J Org Chem"},{"issue":"10","key":"10.1016\/j.xphs.2026.104406_bib0047","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1055\/s-0042-109865","article-title":"Applications of copolymeric nanoparticles in drug delivery systems","volume":"66","author":"Danafar","year":"2016","journal-title":"Drug Res"},{"issue":"10","key":"10.1016\/j.xphs.2026.104406_bib0048","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3390\/pharmaceutics17101360","article-title":"From conventional to next-generation strategies: recent advances in polymeric micelle preparation for drug delivery","volume":"17","author":"Cho","year":"2025","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.xphs.2026.104406_bib0049","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chem Rev"},{"issue":"8","key":"10.1016\/j.xphs.2026.104406_bib0050","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.apsb.2021.03.033","article-title":"Influencing factors and strategies of enhancing nanoparticles into tumors in vivo","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"10.1016\/j.xphs.2026.104406_bib0051","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","article-title":"Dynamic light scattering: a practical guide and applications in biomedical sciences","volume":"8","author":"Stetefeld","year":"2016","journal-title":"Biophys Rev"},{"issue":"2","key":"10.1016\/j.xphs.2026.104406_bib0052","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"issue":"4","key":"10.1016\/j.xphs.2026.104406_bib0053","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today"},{"issue":"6","key":"10.1016\/j.xphs.2026.104406_bib0054","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1002\/jsfa.14109","article-title":"High heterogeneity in the size distribution of the micellar fraction from in vitro digestions: sample preparation and reporting recommendations","volume":"105","author":"Will","year":"2025","journal-title":"J Sci Food Agric"},{"key":"10.1016\/j.xphs.2026.104406_bib0055","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","article-title":"Polymeric micelles in drug delivery: an insight of the techniques for their characterization and assessment in biorelevant conditions","volume":"332","author":"Ghezzi","year":"2021","journal-title":"J Control Release"},{"issue":"11","key":"10.1016\/j.xphs.2026.104406_bib0056","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202500047","article-title":"Evaluation of HER2 targeted poly(ethylene glycol)-poly(L-histidine) copolymer micelles in breast cancer models","volume":"25","author":"Valsala Kumari","year":"2025","journal-title":"Macromol Biosci"},{"issue":"7","key":"10.1016\/j.xphs.2026.104406_bib0057","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1208\/s12249-024-02930-7","article-title":"PEGylated pH-responsive liposomes for enhancing the intracellular uptake and cytotoxicity of Paclitaxel in MCF-7 breast cancer cells","volume":"25","author":"Nijhawan","year":"2024","journal-title":"AAPS PharmSciTech"},{"issue":"7\u20138","key":"10.1016\/j.xphs.2026.104406_bib0058","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10354-016-0432-7","article-title":"Endocytic pathways and endosomal trafficking: a primer","volume":"166","author":"Elkin","year":"2016","journal-title":"Wien Med Wochenschr"},{"issue":"5","key":"10.1016\/j.xphs.2026.104406_bib0059","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3390\/pharmaceutics15051355","article-title":"Core-shell structured PLGA particles having highly controllable Ketoprofen drug release","volume":"15","author":"Varga","year":"2023","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.xphs.2026.104406_bib0060","doi-asserted-by":"crossref","first-page":"11059","DOI":"10.1021\/nn3047605","article-title":"Hydrophobic interactions modulate self-assembly of nanoparticles","volume":"6","author":"Sanchez-Iglesias","year":"2012","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.xphs.2026.104406_bib0061","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jmr.618","article-title":"Long-range and short-range mechanisms of hydrophobic attraction and hydrophilic repulsion in specific and aspecific interactions","volume":"16","author":"van Oss","year":"2003","journal-title":"J Mol Recognit"},{"issue":"4","key":"10.1016\/j.xphs.2026.104406_bib0062","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40005-022-00573-z","article-title":"Smart pH-responsive nanomedicines for disease therapy","volume":"52","author":"Shinn","year":"2022","journal-title":"J Pharm Investig"},{"issue":"3","key":"10.1016\/j.xphs.2026.104406_bib0063","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/AAC.44.3.688-692.2000","article-title":"A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates","volume":"44","author":"Landry","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2026.104406_bib0064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.08.007","article-title":"Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice","volume":"146","author":"Kamiyama","year":"2017","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1016\/j.xphs.2026.104406_bib0065","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1055\/s-0036-1592071","article-title":"Pathogenesis and Molecular mechanisms of Zika Virus","volume":"34","author":"Nayak","year":"2016","journal-title":"Semin Reprod Med"},{"issue":"3","key":"10.1016\/j.xphs.2026.104406_bib0066","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4103\/ijmr.IJMR_169_20","article-title":"Molecular mechanisms of zika virus pathogenesis: an update","volume":"154","author":"Bhagat","year":"2021","journal-title":"Indian J Med Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0067","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41392-024-01745-z","article-title":"Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment","volume":"9","author":"Huang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10.1016\/j.xphs.2026.104406_bib0068","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3390\/v13040667","article-title":"Broad-spectrum antiviral strategies and nucleoside analogues","volume":"13","author":"Geraghty","year":"2021","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.xphs.2026.104406_bib0069","first-page":"218","article-title":"Mechanism of action of ribavirin in the treatment of chronic hepatitis C","volume":"3","author":"Te","year":"2007","journal-title":"Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104406_bib0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/molecules30020210","article-title":"Purine but not pyrimidine de novo nucleotide biosynthesis inhibitors strongly enhance the antiviral effect of corresponding nucleobases against dengue virus","volume":"30","author":"Bonnac","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2026.104406_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2025.101614","article-title":"Novel and repurposed antiviral molecules for arbovirus infections with epidemic potential: a systematic review","volume":"66","author":"Logiudice","year":"2025","journal-title":"New Microbes New Infect"},{"issue":"10","key":"10.1016\/j.xphs.2026.104406_bib0072","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1021\/acsnano.9b02807","article-title":"Orally administrable therapeutic synthetic nanoparticle for Zika Virus","volume":"13","author":"Surnar","year":"2019","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0073","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.diagmicrobio.2019.03.012","article-title":"Lack of efficacy of ivermectin for prevention of a lethal Zika virus infection in a murine system","volume":"95","author":"Ketkar","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.xphs.2026.104406_bib0074","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4269\/ajtmh.24-0183","article-title":"Ivermectin inhibits Zika virus replication in Vitro but does not prevent Zika virus infection in Rhesus macaques (Macaca mulatta)","volume":"112","author":"Cotrone","year":"2025","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0075","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1021\/acsomega.3c06489","article-title":"Short antiangiogenic MMP-2 peptide-decorated conjugated linoleic acid-coated SPIONs for targeted paclitaxel delivery in an A549 cell xenograft mouse tumor model","volume":"9","author":"Ngema","year":"2024","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0076","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13568-025-01876-8","article-title":"Study of anti-toxoplasma gondii effect of mPEG-PCL copolymeric loaded with pyrimethamine, in vitro","volume":"15","author":"Gholami","year":"2025","journal-title":"AMB Express"},{"issue":"21","key":"10.1016\/j.xphs.2026.104406_bib0077","doi-asserted-by":"crossref","DOI":"10.1002\/asia.202400701","article-title":"Rethinking nanoparticle synthesis: a sustainable approach vs. traditional methods","volume":"19","author":"Jain","year":"2024","journal-title":"Chem-Asian J"},{"issue":"5","key":"10.1016\/j.xphs.2026.104406_bib0078","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/0193841X16655665","article-title":"Implications of small samples for generalization: adjustments and rules of thumb","volume":"41","author":"Tipton","year":"2017","journal-title":"Eval Rev"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0079","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/ijms26010047","article-title":"An overview of Zika virus and Zika Virus induced neuropathies","volume":"26","author":"Wahaab","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/liv.13212","article-title":"Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection","volume":"37","author":"Feld","year":"2017","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0081","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/17435889.2024.2421157","article-title":"Overcoming challenges in the design of drug delivery systems targeting the central nervous system","volume":"20","author":"Almutary","year":"2025","journal-title":"Nanomedicine"},{"issue":"9","key":"10.1016\/j.xphs.2026.104406_bib0082","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1021\/acsmacrolett.7b00490","article-title":"Core-shell structure and aggregation number of micelles composed of amphiphilic block copolymers and amphiphilic heterografted polymer brushes determined by small-angle X-ray scattering","volume":"6","author":"Szymusiak","year":"2017","journal-title":"ACS Macro Lett"},{"issue":"9","key":"10.1016\/j.xphs.2026.104406_bib0083","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104406_bib0084","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1021\/acs.nanolett.8b04007","article-title":"Blood circulation-prolonging peptides for engineered nanoparticles identified via phage display","volume":"19","author":"Jin","year":"2019","journal-title":"Nano Lett"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0085","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1021\/bm101254e","article-title":"Backbone degradable multiblock N-(2-Hydroxypropyl)methacrylamide copolymer conjugates via reversible addition-fragmentation chain transfer polymerization and thiol-ene coupling reaction","volume":"12","author":"Pan","year":"2011","journal-title":"Biomacromolecules"},{"issue":"14","key":"10.1016\/j.xphs.2026.104406_bib0086","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1021\/acs.chemrev.8b00199","article-title":"Block copolymer micelles in nanomedicine applications","volume":"118","author":"Cabral","year":"2018","journal-title":"Chem Rev"},{"key":"10.1016\/j.xphs.2026.104406_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2024.117672","article-title":"Nanometrics goes beyond the size: assessment of nanoparticle concentration and encapsulation efficiency in nanocarriers","volume":"174","author":"Marques","year":"2024","journal-title":"Trac-Trend Anal Chem"},{"issue":"5","key":"10.1016\/j.xphs.2026.104406_bib0088","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13050691","article-title":"How to achieve high encapsulation efficiencies for macromolecular and sensitive APIs in liposomes","volume":"13","author":"Ullmann","year":"2021","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.xphs.2026.104406_bib0089","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112394","article-title":"In vitro and In vivo effect of pH-sensitive PLGA-TPGS-based hybrid nanoparticles loaded with doxorubicin for breast cancer therapy","volume":"14","author":"Fernandes","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104406_bib0090","article-title":"Overcoming the application limitations of pH-driven encapsulation of bioactive compounds: strategies and perspectives","volume":"59","author":"Wang","year":"2024","journal-title":"Curr Opin Food Sci"},{"key":"10.1016\/j.xphs.2026.104406_bib0091","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.855019","article-title":"pH-responsive polymer nanomaterials for tumor therapy","volume":"12","author":"Chu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.xphs.2026.104406_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.112783","article-title":"Recent advances in the pH-responsive organic-inorganic mesoporous hybrid silica for targeted drug delivery","volume":"206","author":"Mohan","year":"2024","journal-title":"Eur Polym J"},{"key":"10.1016\/j.xphs.2026.104406_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112249","article-title":"Polymer-hybrid nanosystems for antiviral applications: current advances","volume":"146","author":"Soares","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"23","key":"10.1016\/j.xphs.2026.104406_bib0094","doi-asserted-by":"crossref","DOI":"10.3390\/foods13233945","article-title":"An improved pH-driven method for upcycling polyphenols from plants or byproducts into foods","volume":"13","author":"Gong","year":"2024","journal-title":"Foods"},{"issue":"3","key":"10.1016\/j.xphs.2026.104406_bib0095","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1021\/acs.molpharmaceut.2c00895","article-title":"Impact of gastric pH variations on the release of amorphous solid dispersion formulations containing a weakly basic drug and enteric polymers","volume":"20","author":"Nguyen","year":"2023","journal-title":"Mol Pharmaceut"},{"issue":"11","key":"10.1016\/j.xphs.2026.104406_bib0096","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28114461","article-title":"Efficient pH-responsive nano-drug delivery system based on dynamic boronic acid\/ester transformation","volume":"28","author":"Chen","year":"2023","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.xphs.2026.104406_bib0097","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/jvp.12946","article-title":"Recent advances in microencapsulation of drugs for veterinary applications","volume":"44","author":"Ahmad","year":"2021","journal-title":"J Vet Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.xphs.2026.104406_bib0098","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1208\/s12249-014-0177-9","article-title":"Nanomedicine scale-up technologies: feasibilities and challenges","volume":"15","author":"Paliwal","year":"2014","journal-title":"Aaps Pharmscitech"},{"issue":"26","key":"10.1016\/j.xphs.2026.104406_bib0099","doi-asserted-by":"crossref","first-page":"17685","DOI":"10.1039\/D3RA02883F","article-title":"A recent overview of surfactant-drug interactions and their importance","volume":"13","author":"Pokhrel","year":"2023","journal-title":"RSC Adv"},{"issue":"5","key":"10.1016\/j.xphs.2026.104406_bib0100","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/clpt.2008.110","article-title":"Role of pegylated interferon-alpha-2a and ribavirin concentrations in sustained viral response in HCV\/HIV-coinfected patients","volume":"84","author":"Lopez-Cortes","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.xphs.2026.104406_bib0101","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-22620-2","article-title":"Antiviral effect of ribavirin against HCV associated with increased frequency of G-to-A and C-to-U transitions in infectious Cell Culture Model","volume":"8","author":"Galli","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2026.104406_bib0102","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10198-0","article-title":"Determining Ribavirin's mechanism of action against Lassa virus infection","volume":"7","author":"Carrillo-Bustamante","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2026.104406_bib0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105429","article-title":"Generation of a VeroE6 pgp gene knock out cell line and its use in SARS-CoV-2 antiviral study","volume":"208","author":"Zhu","year":"2022","journal-title":"Antivir Res"},{"key":"10.1016\/j.xphs.2026.104406_bib0104","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jconrel.2023.01.021","article-title":"Accelerated clearance by antibodies against methoxy PEG depends on pegylation architecture","volume":"354","author":"Lin","year":"2023","journal-title":"J Control Rel"},{"issue":"1","key":"10.1016\/j.xphs.2026.104406_bib0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12015-024-10800-9","article-title":"Biological scaffolds in 3D cell models: driving innovation in drug discovery","volume":"21","author":"Dave","year":"2025","journal-title":"Stem Cell Rev Rep"},{"issue":"27","key":"10.1016\/j.xphs.2026.104406_bib0106","doi-asserted-by":"crossref","first-page":"9469","DOI":"10.1073\/pnas.0503879102","article-title":"Mechanics of receptor-mediated endocytosis","volume":"102","author":"Gao","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.xphs.2026.104406_bib0107","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1002\/app.32266","article-title":"Synthesis and characterization of PEG-PCL-PEG triblock copolymers as carriers of doxorubicin for the treatment of breast cancer","volume":"117","author":"Cuong","year":"2010","journal-title":"J Appl Polym Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926002558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926002558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:28:18Z","timestamp":1790803698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926002558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":107,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0022354926002558"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104406","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced Zika virus suppression by coupling ribavirin with biodegradable drug delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"104406"}}